Multibagger pharma stock engaged in the business of manufacturing and trading pharmaceutical products and laboratory testing equipment hit a 5 percent upper circuit following the declaration of bonus issue in the ratio of 3:1.
With a market capitalization of Rs. 333.06 Crores, the shares of Shukra Pharmaceuticals Limited hit a 5 percent upper circuit in the day’s trade at Rs. 304.25. It has delivered multibagger returns of 471 percent in a year.
The board of directors of Shukra Pharmaceuticals Limited has declared to issue bonus shares of the company to its shareholders in the ratio of 3:1 where 3 bonus equity shares will be issued to 1 equity share held as on the record date.
There has also been an approval to increase the authorized share capital of the company from Rs. 12 Crores to Rs. 44 Crores by altering the capital clause of the Memorandum of Association of the company
Shukra Pharmaceuticals Limited is engaged in the business of manufacturing and trading pharmaceutical products and laboratory testing equipment. Its product portfolio includes antibiotics, macrolides, anti-fungal, muscle relaxants, and many more.
Its revenue from operations grew by 187 percent from Rs. 20 Crores in FY22 to Rs. 59 Crores in FY23, accompanied by increasing profits of Rs. 1 Crore to Rs. 4 Crores.
It has reported a return on equity (ROE) of Rs. 21.2 percent and a return on capital employed (ROCE) of 18.8 percent, it is making good returns on its equity and capital employed.
Written by: Bharath K.S
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
